1 / 28

Slide 1

Slide 1. Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting. Slide 2. Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting. Slide 3. Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting. Slide 4. Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting. Slide 5.

lizina
Download Presentation

Slide 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Slide 1 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  2. Slide 2 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  3. Slide 3 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  4. Slide 4 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  5. Slide 5 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  6. Slide 6 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  7. Slide 7 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  8. Slide 8 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  9. Slide 9 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  10. Slide 10 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  11. EGFR Mutation Variant III (EGFRvIII) <br /> Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  12. Epidermal Growth Factor Receptor Mutation (EGFRvIII) Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  13. Epidermal Growth Factor Receptor Mutation (EGFRvIII) Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  14. EGFRvIII in GBM Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  15. Rindopepimut (CDX-110)<br /> Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  16. ACTIVATE/ACT II Trial Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  17. <br />The Apparent Benefit from Rindopepimut<br /> Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  18. <br />ACT III Study Design<br /> Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  19. PFS from Diagnosis Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  20. OS from Diagnosis Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  21. Immune Response and Outcome Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  22. <br />Nearly-Complete Response: GBM<br /> Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  23. <br />Elimination of EGFRvIII in Recurrent Tumor<br /> Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  24. Conclusions Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  25. Slide 25 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  26. Slide 26 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  27. Slide 27 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

  28. Slide 28 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting

More Related